Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell Carcinoma

SIMPLE SUMMARY: We investigated survival outcomes following first-line chemotherapy before and after approval of bevacizumab for ovarian cancer in Japan to evaluate the efficacy of bevacizumab for advanced clear cell carcinoma. We investigated 28 consecutive patients diagnosed with clear cell carcin...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancers (Basel)
Huvudupphovsmän: Tate, Shinichi, Nishikimi, Kyoko, Matsuoka, Ayumu, Otsuka, Satoyo, Shiko, Yuki, Ozawa, Yoshihito, Kawasaki, Yohei, Shozu, Makio
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2021
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8268306/
https://ncbi.nlm.nih.gov/pubmed/34202220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133177
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk